Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies
- Written by ACN Newswire - Press Releases
Read more //?#
.
2025 Thryv Business and Consumer Report - Australian small businesses show grit under pressure
Australia’s small businesses are powering ahead with optimism, resilience and discipline, however, mounting pressures on costs, wellbeing and cons...
Security by Default: Why 2026 Will Force Organisations to Rethink Cloud and AI
financial accountability to how they run cloud and AI, according to leading Australian systems integrator, Brennan. Based on customer insights...
UNSW launches plan to help Aussie startups scale overseas
UNSW Launches Global Innovation Foundry to Scale 100 Australian Startups Internationally New initiative provides startups and spinouts with direc...
Payroll Under Pressure: Why Mid-Sized SMEs Struggle to Keep Pay Accurate
A year after wage theft reforms came into effect, Australian businesses have increased their focus on payroll compliance, but confidence in pay accu...
Refunds to Revenue: AI and loyalty perks help retailers in post-holiday hangover
Australian retailers are turning to artificial intelligence to simplify and automate returns and exchanges, while strengthening loyalty programs a...
Stop reading from the script: Why authenticity is the customer success secret weapon
I’ve been in customer service for years now. As my team has grown, the number one piece of advice I give is to be your...